share_log

Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

SEC ·  Aug 9, 2022 08:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more